重组酿酒酵母表达幽门螺杆菌VacA蛋白及其免疫原性分析*

目的:利用酿酒酵母表面展示技术筛选幽门螺杆菌候选疫苗,并分析其免疫原性。方法:以幽门螺杆菌的空泡型细胞毒素A(vacA)基因作为研究对象,构建重组S.cerevisiae EBY100/pYD1-VacA,通过Western blot、免疫荧光标记和流式细胞仪对S.cerevisiae EBY100/pYD1-VacA进行体外表达分析。以PBS和S.cerevisiae EBY100/pYD1为对照组,S.cerevisiae EBY100/pYD1-VacA为实验组,口服免疫SPF级BALB/c小鼠。通过ELISA分析检测口服免疫后小鼠抗VacA特异性IgG及分泌型IgA效价。结果:VacA抗原蛋白被成功地展示在S.cerevisiae EBY100表面。小鼠经口服免疫S.cerevisiae EBY100/pYD1-VacA后可诱导产生较高的VacA特异性抗体。结论:表面展示型酿酒酵母可以作为幽门螺杆菌候选疫苗的递送载体,与此同时,这也为开发其他细菌或病毒疫苗提供新思路。     

环糊精葡萄糖基转移酶的酿酒酵母表面展示及其生产2-O-α-D-吡喃葡萄糖基抗坏血酸

摘要:【目的】将环状芽孢杆菌251(Bacillus circulans 251)来源的环糊精葡萄糖基转移酶(Cyclodextrin Glycosyltransferase,CGTase)展示在酿酒酵母( Saccharomyces cerevisiae)细胞表面,构建全细胞催化剂生产2-O-α-D-吡喃葡萄糖基抗坏血酸(2-O-α-D-glucopyranosyl-L-ascorbic acid,AA-2G),以提高AA-2G 的产量。【方法】将CGTase编码基因cgt连接到载体质粒pYD1中的a凝集素(a-agglutinin)Aga2p亚基基因的下游构建表面展示重组质粒pYD1-cgt,转化酿酒酵母EBY100获得重组菌EBY100-pYD1-cgt,对发酵条件(培养基、诱导温度和诱导剂半乳糖浓度)进行优化;同时先后对重组菌的发酵产酶以及表面展示CGTase的酶促合成AA-2G的条件进行了优化;进一步又比较了表面展示的CGTase与E.coli BL21发酵所得的游离CGTase在酶促制备AA-2G过程中副产物的积累情况。【结果】展示CGTase的酿酒酵母重组菌株以YPG培养基作为发酵培养基,诱导剂半乳糖初始添加浓度为20 g/L,经25 ℃诱导48 h后,表面展示CGTase最大酶产量为0.5 U/mL;表面展示CGTase 40 ℃条件下的温度稳定性比游离酶有所提高,pH稳定范围变宽。对表面展示的CGTase制备AA-2G转化条件的优化发现,其最适温度最适pH分别为30 ℃和4.5,转化48 h达到平衡,表面展示的CGTase制备AA-2G的产量较游离酶提高了37%。【结论】对于CGTase,a凝集素系统是一个有效的展示系统,构建的酿酒酵母全细胞催化剂用于酶促制备AA-2G时,产生的副产物葡萄糖可能被酵母细胞利用,从而降低了葡萄糖与VC的竞争作用使AA-2G的产量增加,该全细胞催化剂具有良好的应用前景。     

木糖异构酶在酿酒酵母细胞表面的展示

将来源于嗜热细菌Thermus thermophilus的木糖异构酶基因xylA,与酿酒酵母(Sac-charomyces cerevisiae)a-凝集素表面展示载体pYD1的Aga2p亚基C端序列融合。编码融合蛋白的基因序列前接上半乳糖诱导型启动子。用LiAc完整细胞法转化酿酒酵母EBY100。含重组质粒的菌株EBY100/pYD-xylA经半乳糖诱导表达外源融合蛋白,免疫荧光显微镜结果显示外源蛋白被锚定在细胞壁上,木糖异构酶活性测定结果表明,细胞壁上酶活测定值为1.52U,木糖异构酶在酿酒酵母细胞壁上得到活性表达。     

酿酒酵母表面展示鲑鱼降钙素多肽的研究

目的:实现酿酒酵母表面展示鲑鱼降钙素.方法:人工合成鲑鱼降钙素(Salmon cacitonin,sCT)编码基因,克隆到表面展示载体M-pYD1上.用NocⅠ酶切重组质粒M-pYD1-sCT和空白质粒M-pYD1,回收sCT和V5表达框片段后分别以LiAC法转化酿酒酵母EBY100菌株,分别得到重组酵母yAGA2-sCT和yAGA2-V5.两种重组酵母分别经半乳糖诱导表达后,采用FITC荧光标记酵母表面展示的sCT和V5多肽,分别用荧光显微镜和流式细胞仪进行定性和定量分析.结果:诱导12h后,荧光显微镜下清晰观测到了工程菌表面有重组sCT,流式细胞分析结果表明10000个细胞中65.2%的yAGA2-sCT菌株表达了外源sCT,52.4%的yAGA2-V5菌株表达V5.结论:利用酿酒酵母表面展示鲑鱼降钙素多肽获得了成功,为口服型鲑鱼降钙素的研发奠定了基础.     

甲基对硫磷水解酶的酿酒酵母表面展示及在甲基对硫磷降解中的应用

PCR扩增假单胞菌WBC-3的甲基对硫磷水解酶基因,插入表面展示质粒pYD1的多克隆位点,构建pYD1-MPH重组质粒。重组质粒转化酿酒酵母EBY100,2%半乳糖诱导甲基对硫磷水解酶表达,并利用免疫荧光检测甲基对硫磷水解酶在酿酒酵母细胞表面的表达展示。研究了表面展示甲基对硫磷水解酶的酶学性质和酵母工程菌对水体中甲基对硫磷的降解效果。结果表明成功构建具有全细胞甲基对硫磷水解酶催化活性的酵母工程菌,经2%半乳糖诱导48 h,表面展示甲基对硫磷水解酶比酶活力为18.2 U/mg细胞干重。表面展示甲基对硫磷水解酶的最适作用pH为9.5,最适作用温度为30℃,在p H4.0-10.5之间和45℃以下稳定性较好,Mn2+、Co2+、Zn2+、Ca2+、Hg2+、K+、Ni2+对表面展示甲基对硫磷水解酶活性有激活作用,Na+、Fe3+、Ag+对展示酶活力有抑制作用。工程菌在1 h内对淡水中20 mg/L的甲基对硫磷的降解率在80%以上。     

鲤春病毒血症病毒G蛋白的研究进展

鲤春病毒血症病毒(Spring viremia of carp virus,SVCV)是引起鱼类传染性病毒病鲤春病毒血症(Spring viremia of carp,SVC)的病原,对鲤科鱼类养殖业造成巨大的经济损失。囊膜糖蛋白G可介导病毒内吞,还是最主要的抗原决定簇蛋白,已成为国内外研究的热点。综述G蛋白在表达技术、病毒检测、疫苗研制等方面的研究状况,旨在为G蛋白的深入研究及鲤春病毒血症的防治提供参考。     

酵母表面展示T载体构建及目的蛋白的表面展示

构建一种能对PCR产物进行直接克隆并展示于酵母表面的新型T载体。根据酵母表面展示载体p YD1多克隆位点序列设计出利用两端带有XcmⅠ内切酶酶切位点的含有黄色荧光蛋白基因的XcmⅠ酶切盒,通过NheⅠ和XhoⅠ酶切位点插入到p YD1载体上形成质粒p YD-YFP,并对其进行酶切鉴定和DNA测序分析,再经XcmⅠ酶切后形成两端带有d T的表面展示T载体。利用PCR扩增两个含有荧光蛋白的融合蛋白PCAD-CFP和PSR-Ds Red的基因并直接克隆到所构建的T载体中,检测其表达功能。酶切鉴定和DNA测序结果显示PCAD-CFP和PSR-Ds Red正确插入载体上,分别转化至酿酒酵母EBY100中,激光共聚焦显微镜下观察到相应的荧光的酵母,表明克隆有融合蛋白基因片段的载体成功在酵母细胞中进行表面展示,证明了所构建的酵母表面展示T载体具有直接克隆和表面展示目的蛋白的功能。     

鲤Pdcd6ip蛋白真核表达载体的构建及抗病毒功能研究

为进一步研究程序性细胞死亡6互作蛋白Pdcd6ip (Programmed cell death 6-interacting protein)分子功能, 探讨其表达对鲤春病毒血症病毒 (Spring viraemia of carp virus, SVCV)增殖的影响, 研究通过逆转录-聚合酶链式反应扩增得到两端带有Nhe I和EcoR I酶切位点的pdcd6ip编码片段, 并将其克隆至真核表达载体pCI-neo上, 构建了真核表达质粒pCI-pdcd6ip。获得的过表达质粒转染至EPC细胞后进行RT-qPCR和western blot检测Pdcd6ip的表达情况, 并利用CCK-8法检测其对细胞增殖的影响。细胞转染后24h进行SVCV感染, 检测Pdcd6ip过表达对SVCV增殖的影响。结果显示, Pdcd6ip蛋白真核重组质粒能够在EPC细胞中大量表达, 转染后72h细胞活性较对照组无显著差异。同时, 免疫荧光、RT-qPCR和western blot检测结果均显示, Pdcd6ip蛋白过表达后, SVCV M蛋白mRNA水平和蛋白表达水平较对照组显著下降, 表明Pdcd6ip过表达显著抑制了SVCV的增殖。研究为抗SVCV药物的研发提供了新的研究基础和设计思路。     

南极假丝酵母脂肪酶A的表面展示及酶学性质研究

采用a凝集素作为载体蛋白,首次将南极假丝酵母脂肪酶A展示在酿酒酵母细胞表面,通过MD平板筛选获得表面展示型的CALA酵母工程菌株。免疫荧光检测显示CALA被成功展示在酵母细胞壁表面,重组子经诱导后能在三丁酸甘油酯板上形成透明圈,说明展示的CALA具有活性。重组酵母在液体培养基培养72 h,活性达到最高,为80.4 U/g干细胞。酿酒酵母展示的CALA最适温度及pH值为70°C和pH 8.0。经50°C保温2 h,仍含有60%水解酶活力。展示的CALA在pH 7.0和pH 8.0溶液中比较稳定。经DMSO处理2 h,展示的CALA仍保持70%的活性。以上结果表明酵母展示的CALA可作为一种有潜质商业用途的全细胞催化剂。     

HIV-1 gp41的酵母表面展示及表达优化

以His标签检测蛋白的表达, 利用酿酒酵母表面展示系统, 成功地将HIV-1 gp41片段锚定在酵母表面, 并检测到gp41的活性。以pMD18T-gp41为模板, 通过PCR技术克隆了gp41基因, 将gp41基因通过双酶切连接到载体pICAS-His上,构建了gp41酵母表面展示载体, 并将其转化至酿酒酵母(Saccharomyces cerevisiae)MT8-1中。重组菌经培养, 利用免疫荧光染色方法进行染色, 显微镜观察发现重组酵母细胞表面有绿色荧光, 流式细胞仪结果进一步证实gp41正确折叠展示于酵母细胞表面。采用不同浓度的葡萄糖培养基进行表达优化。当葡萄糖浓度为1%时, 82.46%的酵母细胞表达了gp41抗原; 随着葡萄糖浓度升高, 蛋白表达受到抑制。     

Immobilization of UDP-galactose 4-epimerase from Escherichia coli on the yeast cell surface

UDP-galactose 4-epimerase (EC 5.1.3.2, Gal E) from Escherichia coli catalyzes the reversible reaction between UDP-galactose and UDP-glucose. In this study, the Gal E gene from E. coli, coding UDP-galactose 4-epimerase, was cloned into pYD1 plasmid and then transformed into Saccharomyces cerevisiae EBY100 for expression of Gal E on the cell surface. Enzyme activity analyses with EBY100 cells showed that the enzyme displayed on the yeast cell surface was very active in the conversion between UDP-Glc and UDP-Gal. It took about 3 min to reach equilibrium from UDP-galactose to UDP-glucose.     

Immobilization of UDP-Galactose 4-Epimerase from Escherichia coli on the Yeast Cell Surface

UDP-galactose 4-epimerase (EC 5.1.3.2, Gal E) from Escherichia coli catalyzes the reversible reaction between UDP-galactose and UDP-glucose. In this study, the Gal E gene from E. coli, coding UDP-galactose 4-epimerase, was cloned into pYD1 plasmid and then transformed into Saccharomyces cerevisiae EBY100 for expression of Gal E on the cell surface. Enzyme activity analyses with EBY100 cells showed that the enzyme displayed on the yeast cell surface was very active in the conversion between UDP-Glc and UDP-Gal. It took about 3 min to reach equilibrium from UDP-galactose to UDP-glucose.     

Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle

The expression of proliferating cell nuclear antigen (PCNA), also called cyclin, was quantified in the cell lines SP2/0 and MOLT-4 and in mouse splenocytes induced to proliferate in vitro with mitogens. Autoantibody from a patient with systemic lupus erythematosus was used to label PCNA in cell suspensions after the cells had been fixed and permeabilized. In the same cells DNA was stained by propidium iodide. The cells were then analysed by flow cytometry for PCNA and DNA content. The PCNA profiles in proliferating spleen cells and the cell lines were similar. Most G0-G1 cells did not express significant amount of PCNA. A dramatic increase in PCNA immunofluorescence was observed in late G1 cells, and further increases were observed in S-phase cells. G2-M cells showed a reduced level of PCNA immunofluorescence relative to S-phase cells but were still elevated relative to G0-G1 cells. Proliferating cells arrested at the G1-S boundary by exposure to cytosine arabinoside showed an increased PCNA immunofluorescence as compared to unstimulated cells.     

Construction and characterization of a thermostable whole-cell chitinolytic enzyme using yeast surface display

To develop a novel yeast whole-cell biocatalyst by yeast surface display technology that can hydrolyze chitin, the chitinaseC gene from Serratia marcescens AS1.1652 strain was cloned and subcloned into the yeast surface display plasmid pYD1, and the recombinant plasmid pYD1/SmchiC was electroporated into Saccharomyces cerevisiae EBY100 cell. Aga2p-SmChiC fusion protein was expressed and anchored on the yeast cell surface by induction with galactose, which was verified by indirect immunofluorescence and Western blotting. The chitinolytic activity of the yeast whole-cell biocatalyst or partially purified enzyme was detected by agar plate clear zone test, SDS-PAGE zymography and dinitrosalicylic acid method. The results showed that the chitinaseC gene from S. marcescens AS1.1652 strain was successfully cloned and expressed on the yeast cell surface, Aga2p-SmChiC fusion protein with molecular weight (67 kDa) was determined. Tests on the effect of temperature and pH on enzyme activity and stability revealed that the yeast whole-cell biocatalyst and partially purified enzyme possessed both thermal stability and activity, and even maintained some activity under acidic and weakly alkaline conditions. The optimum reaction temperature and pH value were set at 52 °C and 5.0, respectively. Yeast surface display technology succeeded in preparing a yeast whole-cell biocatalyst with chitinolytic activity, and the utilization of chitin could benefit from this process of enzyme preparation.     

HCVNS3基因片段酵母展示文库的构建和鉴定

 HCV NS3特异的 CD4+T细胞反应与 HCV感染的良性转归相关 .为了筛选其 CD4+T细胞表位 ,构建了 HCV NS3基因片段酵母展示文库 .首先 DNase 不完全酶切 HCV NS3基因产生长度为 1 0 0～ 30 0 bp的随机片段 ,然后在它们两端加上含限制性内切酶 Bam H 作用位点的接头 ,再以接头序列作引物进行 PCR扩增 .最后扩增产物用 Bam H 酶切后与 Bam H 线性化的穿梭载体 p YD1连接 ,转化大肠杆菌 (E.coli) DH5α,共得到 2× 1 0 6个转化子 .转化菌落的 PCR扩增结果表明 ,约 50 %转化子含插入片段 .随机选择 5个插入片段测序 ,然后与 DNA序列数据库中的序列比较 .结果显示它们分别与 HCV NS3序列有 96%～ 99%的同源性 .用从转化菌落中提取的质粒转化酵母 (S.cerevisiae)菌株 EBY1 0 0 ,得到含 2× 1 0 5个插入片段的 HCV NS3基因片段酵母展示文库 .半乳糖诱导的酵母细胞通过和 FITC标记的抗体结合 ,用 FACS可以在 2 0 %的细胞表面检测到融合蛋白的表达 .     

Characterization of the energy-dependent, mating factor-activated Ca influx in Saccharomyces cerevisiae

The yeast mating pheromones, a and alpha factors, bind to specific G protein-coupled receptors in haploid cells and bring about both growth arrest in the early G1 phase of the cell cycle and differentiation into mating capable cells. This induces an increase in Ca2+ influx leading to elevated intracellular calcium concentrations, which has been shown to be essential for subsequent downstream events and the mating process itself [1]. We have characterized the alpha factor induced increase in cellular Ca2+ in wild type S. cerevisiae and in the temperature-sensitive cell division cycle mutants cdc7 and cdc28 which are growth-arrested at the G0-G1 border at the nonpermissive temperature. We observed a 2-4 fold increase in the initial velocity of Ca2+ influx in alpha factor-treated wild-type cells and in cdc7 and cdc28 cells grown at the nonpermissive temperature. Calcium influx was energy dependent, inhibited by membrane depolarization and slightly increased by hyperpolarization. Furthermore, Ca2+ influx was sensitive to both divalent and trivalent cations, but was unaffected by nifedipine and verapamil. These data demonstrate that budding yeast possesses a regulated Ca2+ transport mechanism, the activation of which is dependent upon exit out of the cell cycle and growth cessation. This transport mechanism has many similarities to that observed in mitogen-stimulated mammalian cells.     

G6PD通过细胞周期蛋白D1/D2调控人黑色素瘤细胞周期的进程

葡萄糖-6-磷酸脱氢酶(G6PD)在人皮肤黑色素瘤A375细胞中处于高表达与高活性状态, 但G6PD在黑色素瘤发生发展过程中的作用及其具体机制尚不明确.本文在前期运用 siRNA方法构建G6PD敲减的黑色素瘤A375稳转细胞(A375-G6PDΔ)基础上,构建表达载体pBabe-puro-G6PDWT在A375-G6PDΔ细胞中过表达野生型的G6PD基因,从而构建G6PD表达恢复的稳转细胞(A375-G6PDΔ-G6PDWT).3株细胞A375-WT、A375-G6PDΔ和 A375-G6PDΔ-G6PDWT经G6PD酶活性测定、MTT测定、克隆形成实验、流式细胞仪分析细胞周期和Western 印迹检测.结果显示,A375-G6PDΔ-G6PDWT细胞的G6PD蛋白表达量 (0.847 ± 0.080)及其活性(0.394 ± 0.029)分别是A375-G6PDΔ的3.28倍(P＜0.01) 和7.34倍(P＜0.01),分别是A375-WT细胞的91-57%和2.12倍(P＜0.05).与A375-WT细 胞相比,A375-G6PDΔ细胞G0/G1期细胞数增加,S期细胞数减少,增殖指数PI降低了25-70%（P＜0.05）,细胞周期蛋白D1/D2、细胞周期蛋白E表达分别下降37.4%、54.3% (P＜0.01)和17.3%;而A375-G6PDΔ-G6PDWT细胞呈现G1/S期阻滞解除,细胞周期蛋白D1/D2蛋白分别恢复到A375-WT细胞的89.5%和87.6%,细胞周期蛋白E表达未见 恢复,呈现生长增殖和克隆形成率的恢复并接近于A375-WT细胞. 结果提示,G6PD通 过细胞周期蛋白D1/D2调控人皮肤黑色素瘤A375细胞G1期向S期转换的进程,这为黑色 素瘤发病机制的研究提供了新的思路.     

G6PD缺陷通过Caspase-3和PARP-1诱导人黑色素瘤细胞凋亡

葡糖-6-磷酸脱氢酶(G6PD)在许多肿瘤细胞中高表达,但其发生的作用机理目前仍然不明确.以正常人表皮黑色素细胞(HEM)、野生型人黑色素瘤A375细胞(A375-WT)和G6PD缺陷的A375细胞(A375-G6PDΔ)为对象,经real-time PCR、Western印迹和紫外分光光度法分析显示,A375-WT细胞的mRNA、G6PD蛋白和G6PD活性分别是HEM细胞的1.89倍(P0.05)、6.86倍(P0.01)和2.30倍(P0.05).Annexin V/PI流式细胞仪和Western印迹测定表明,A375-G6PDΔ的凋亡率是A375-WT的5.10倍(P0.01),活化半胱氨酸蛋白酶3(caspase-3)增高1.84倍(P0.01)以及89 kD多聚二磷酸腺苷核糖聚合酶-1(PARP-1)生成增加2.87倍(P0.01).分光光度法分析显示,A375-G6PDΔ的NADPH和GSH分别降低了72.30%(P0.01)和27.39%(P0.05),并伴有75.43%的H2O2增高(P0.01).结果提示,G6PD在黑色素瘤细胞中高表达和高活性,而敲减G6PD表达通过caspase-3和PARP-1信号诱发人黑色素瘤细胞凋亡,这为深入揭示黑色素瘤的发生机理提供了新思路。